Security key
48669G303
KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA)
CUSIP: 48669G303
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / American Depositary Shares, each representing five-hundred Ordinary Shares
- Total 13F shares
- 64,136
- Total 13F value
- $614,432
- Share change
- +62,210
- SEC-reported price per share
- $9.60
- Number of holders
- 3
- Value change
- +$595,952
- Number of buys
- 3
- Shares outstanding
- 11,750,571
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
3
Top holders
3
KZIA full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
KAZIA THERAPEUTICS LTD SEC filings
KAZIA THERAPEUTICS LTD company facts
Broader feeds
Reporting periods
Holder history for CUSIP 48669G303
Recent filing periods:
Ownership snapshot
Top reported holders of KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Jorey Chernett
Disclosed value leader
Lynwood Capital Managemen...
Comparable rows
15/15
Latest evidence
05 Aug 2026
13D/G
13F
Lead comparable stake: 20%
13D/G row: Jorey Chernett
Showing 1-6 of 15 holder rows.
Quick read
Jorey Chernett leads the comparable SEC ownership view at 20%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Jorey Chernett's linked filing trail.
Comparable ownership
Top 5
Jorey Chernett
20%
Alumni Capital LP
10%
Dauntless Investment Group, LLC
5.4%
Ikarian Capital, LLC
4.9%
Lynwood Capital Management Inc.
4.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Jorey Chernett |
13D/G
Chernett Jorey
|
20%
|
—
2,339,009 shares
|
$0 | 05 Aug 2026 |
| Alumni Capital LP |
13D/G
|
10%
|
—
178,591 shares
|
$0 | 31 Jul 2025 |
| Dauntless Investment Group, LLC |
13F
13D/G
Company
|
5.4%
from 13D/G
|
$4,987,249
354,208 shares
|
— | 30 Jun 2026 |
| Ikarian Capital, LLC |
13D/G
13F
Company
|
4.9%
|
$7,824,823
575,778 shares
|
-$67,624 | 30 Jun 2026 |
| Lynwood Capital Management Inc. |
13D/G
|
4.6%
|
$3,601,084,995
264,980,500 shares
|
-$584,614,620 | 30 Jun 2026 |
| Boxer Capital Management, LLC |
13F
Company
|
4.8%
|
$7,884,800
560,000 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
3
Shares
64,136
Rows available
3
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q1 2026 Across Filers
Q1 2026 holders
23
Q3 2026 holders
3
Holder diff
-20
| Investor | Q1 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend